Wordt geladen...
Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
BACKGROUND: Proper blocking of toll-like receptor (TLR) activation during disease progression has been reported to have inhibitory effect on the pathogenesis of rheumatoid arthritis (RA). We tested whether the TLR4 inhibitor TAK-242 had potential as a remedy for rheumatoid arthritis. METHODS: The th...
Bewaard in:
| Gepubliceerd in: | Arthritis Res Ther |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6979396/ https://ncbi.nlm.nih.gov/pubmed/31973752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-2097-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|